- Drug Pipelines
- November 2020
- 68 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- December 2023
- 25 Pages
Germany
From €825EUR$917USD£734GBP
- Report
- October 2023
- 24 Pages
Taiwan
From €825EUR$917USD£734GBP
- Report
- September 2023
- 25 Pages
Australia
From €825EUR$917USD£734GBP
- Report
- September 2023
- 27 Pages
Canada
From €825EUR$917USD£734GBP
From €825EUR$917USD£734GBP
- Report
- September 2023
- 23 Pages
China
From €825EUR$917USD£734GBP
- Report
- September 2023
- 26 Pages
France
From €825EUR$917USD£734GBP
- Report
- September 2023
- 25 Pages
Italy
From €825EUR$917USD£734GBP
- Report
- September 2023
- 27 Pages
United Kingdom
From €825EUR$917USD£734GBP
- Report
- September 2020
- 117 Pages
South Africa
From €2409EUR$2,500USD£2,072GBP
- Report
- October 2022
- 42 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- March 2024
- 29 Pages
Brazil
From €825EUR$917USD£734GBP
- Report
- February 2024
- 24 Pages
China, Hong Kong
From €825EUR$917USD£734GBP
- Report
- January 2024
- 24 Pages
Thailand
From €825EUR$917USD£734GBP
- Report
- January 2024
- 20 Pages
Cameroon
From €825EUR$917USD£734GBP
- Report
- January 2024
- 23 Pages
Kenya
From €825EUR$917USD£734GBP
- Report
- January 2024
- 23 Pages
Nigeria
From €825EUR$917USD£734GBP
- Report
- November 2023
- 25 Pages
Switzerland
From €825EUR$917USD£734GBP
- Report
- November 2023
- 24 Pages
India
From €825EUR$917USD£734GBP
The Cold Sore Drug market is a subset of the Infectious Diseases Drugs market. Cold Sores, also known as fever blisters, are caused by the herpes simplex virus and are highly contagious. Cold Sore Drugs are used to treat the symptoms of the virus, such as pain, itching, and burning. These drugs can also help reduce the duration of the outbreak and prevent future outbreaks. Commonly used Cold Sore Drugs include antiviral medications, topical creams, and ointments.
The Cold Sore Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include Sanofi, Bayer, and Mylan. Show Less Read more